DD150205A5 - Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure - Google Patents
Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure Download PDFInfo
- Publication number
- DD150205A5 DD150205A5 DD80220683A DD22068380A DD150205A5 DD 150205 A5 DD150205 A5 DD 150205A5 DD 80220683 A DD80220683 A DD 80220683A DD 22068380 A DD22068380 A DD 22068380A DD 150205 A5 DD150205 A5 DD 150205A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- salt
- methyl
- oxa
- acetone
- carboxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/032,840 US4259485A (en) | 1979-04-24 | 1979-04-24 | Crystallization process |
Publications (1)
Publication Number | Publication Date |
---|---|
DD150205A5 true DD150205A5 (de) | 1981-08-19 |
Family
ID=21867102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD80220683A DD150205A5 (de) | 1979-04-24 | 1980-04-24 | Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure |
Country Status (34)
Country | Link |
---|---|
US (1) | US4259485A (xx) |
EP (1) | EP0018760B1 (xx) |
JP (1) | JPS55143992A (xx) |
KR (1) | KR840000036B1 (xx) |
AR (1) | AR225174A1 (xx) |
AT (1) | AT368158B (xx) |
AU (1) | AU531272B2 (xx) |
BE (1) | BE882849A (xx) |
BG (1) | BG34904A3 (xx) |
CA (1) | CA1124236A (xx) |
CH (1) | CH645901A5 (xx) |
CS (1) | CS212347B2 (xx) |
DD (1) | DD150205A5 (xx) |
DE (1) | DE3067412D1 (xx) |
DK (1) | DK172880A (xx) |
EG (1) | EG14334A (xx) |
ES (1) | ES8200110A1 (xx) |
FI (1) | FI801252A (xx) |
FR (1) | FR2455043A1 (xx) |
GB (1) | GB2047703B (xx) |
GR (1) | GR68048B (xx) |
HU (1) | HU182127B (xx) |
IE (1) | IE49703B1 (xx) |
IL (1) | IL59895A (xx) |
IT (1) | IT1141294B (xx) |
LU (1) | LU82384A1 (xx) |
NZ (1) | NZ193482A (xx) |
PH (1) | PH15146A (xx) |
PL (1) | PL124423B1 (xx) |
PT (1) | PT71115A (xx) |
RO (1) | RO79315A (xx) |
SU (1) | SU925251A3 (xx) |
YU (1) | YU108180A (xx) |
ZA (1) | ZA802329B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56103185A (en) * | 1980-01-22 | 1981-08-18 | Shionogi & Co Ltd | Malonamidoxa-dethia-cephem compound |
JPS5711909A (en) * | 1980-06-23 | 1982-01-21 | Shionogi & Co Ltd | Stable freeze-dried preparation of beta-lactam |
JPS597193A (ja) * | 1982-07-02 | 1984-01-14 | Shionogi & Co Ltd | マロニルメチル基の異性化方法 |
RU2555360C2 (ru) * | 2012-11-06 | 2015-07-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ определения воды в координационных соединениях |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1085392A (en) * | 1976-03-25 | 1980-09-09 | Masayuki Narisada | Arylmalonamido-1-oxadethiacephalosporins |
AU514377B2 (en) * | 1977-02-15 | 1981-02-05 | Shionogi & Co., Ltd. | l-OXADETHIACEPHAM COMPOUNDS |
CA1100962A (en) * | 1977-04-28 | 1981-05-12 | Yoshio Hamashima | Haloarylmalonamidooxacephalosporins |
JPS609718B2 (ja) * | 1977-08-25 | 1985-03-12 | 塩野義製薬株式会社 | チアジアゾリルチオセフアロスポリン類縁抗生物質 |
BE871213R (fr) * | 1978-10-12 | 1979-02-01 | Shionogi & Co | Arylmalonamido-1-oxadethiacephalosporines |
-
1979
- 1979-04-24 US US06/032,840 patent/US4259485A/en not_active Expired - Lifetime
-
1980
- 1980-04-17 AT AT0207380A patent/AT368158B/de not_active IP Right Cessation
- 1980-04-18 FR FR8008779A patent/FR2455043A1/fr active Granted
- 1980-04-18 BE BE1/9791A patent/BE882849A/fr not_active IP Right Cessation
- 1980-04-18 NZ NZ193482A patent/NZ193482A/xx unknown
- 1980-04-18 CS CS802746A patent/CS212347B2/cs unknown
- 1980-04-18 GB GB8012882A patent/GB2047703B/en not_active Expired
- 1980-04-18 DE DE8080301269T patent/DE3067412D1/de not_active Expired
- 1980-04-18 CA CA350,223A patent/CA1124236A/en not_active Expired
- 1980-04-18 FI FI801252A patent/FI801252A/fi not_active Application Discontinuation
- 1980-04-18 EP EP80301269A patent/EP0018760B1/en not_active Expired
- 1980-04-18 PT PT71115A patent/PT71115A/pt unknown
- 1980-04-18 ZA ZA00802329A patent/ZA802329B/xx unknown
- 1980-04-19 GR GR61721A patent/GR68048B/el unknown
- 1980-04-21 RO RO80100909A patent/RO79315A/ro unknown
- 1980-04-21 PH PH23926A patent/PH15146A/en unknown
- 1980-04-21 PL PL1980223649A patent/PL124423B1/pl unknown
- 1980-04-21 YU YU01081/80A patent/YU108180A/xx unknown
- 1980-04-21 IT IT21527/80A patent/IT1141294B/it active
- 1980-04-21 AU AU57633/80A patent/AU531272B2/en not_active Expired - Fee Related
- 1980-04-22 BG BG8047486A patent/BG34904A3/xx unknown
- 1980-04-22 EG EG246/80A patent/EG14334A/xx active
- 1980-04-22 AR AR280762A patent/AR225174A1/es active
- 1980-04-22 IL IL59895A patent/IL59895A/xx not_active IP Right Cessation
- 1980-04-22 CH CH309480A patent/CH645901A5/fr not_active IP Right Cessation
- 1980-04-22 HU HU80987A patent/HU182127B/hu not_active IP Right Cessation
- 1980-04-22 LU LU82384A patent/LU82384A1/fr unknown
- 1980-04-22 IE IE804/80A patent/IE49703B1/en not_active IP Right Cessation
- 1980-04-23 ES ES490828A patent/ES8200110A1/es not_active Expired
- 1980-04-23 SU SU802912148A patent/SU925251A3/ru active
- 1980-04-23 JP JP5485180A patent/JPS55143992A/ja active Granted
- 1980-04-23 DK DK172880A patent/DK172880A/da not_active IP Right Cessation
- 1980-04-24 KR KR1019800001690A patent/KR840000036B1/ko active
- 1980-04-24 DD DD80220683A patent/DD150205A5/de unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69301571T2 (de) | Verfahren zur Herstellung von Clavulansäure | |
AT399155B (de) | Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung | |
WO1993010118A1 (de) | Verfahren zur trennung von 5-methyl-tetrahydrofolsäure | |
EP0112550B1 (de) | Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung | |
DD284807A5 (de) | Verf. z. herstellung eine pyhsikalischen gemisches aus mindestens einem salz des ((1-methyl-1-pyrrolidinio)- methyl)-3-cephem-4-carboxylats u. einer pharmazeutisch vertraeglichen, nicht toxischen, organischen oder anorganischen base | |
EP0078532B1 (de) | Kristalline Salze von Cefodizim und Verfahren zu ihrer Herstellung | |
DE19807972A1 (de) | Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung | |
DE3780382T2 (de) | Metall komplexe von n-methyl-11-aza-10-deoxy-10-dihydroerythromycin-a oder von 11-aza-10-deoxy-10-dihydroxyerythromycin-a, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen praeparaten. | |
DE2614669C2 (de) | Gamma-kristalline wasserfreie Form von 7-(D-alpha-Formyloxy-alpha-phenylacetamido)-3-(1-methyl-1H-tetrazol-5- ylthiomethyl)-3-cephem-4-natriumcarboxylat und Verfahren zu ihrer Herstellung | |
DD150205A5 (de) | Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure | |
DE2066118C3 (de) | 14-Desoxy-14-tosyloxyacetoxymutilin und Verfahr en zu dessen Herstellung | |
DE69107098T2 (de) | 2'-Deoxy-2'-Methylidenecytidin-dihydrat, Verfahren zu ihrer Herstellung und Mischmaterial. | |
DE1143817C2 (de) | Verfahren zur Herstellung von 6-Phenoxyacylamidopenicillansaeure-derivaten und von nicht giftigen Salzen derselben | |
DE3302699C2 (de) | N-Methansulfonsäure-Derivate von 3-0-Desmethylistamycin B, Verfahren zu ihrer Herstellung und solche Derivate enthaltende pharmazeutische Mittel | |
DE2825289A1 (de) | 1-n-(omega-aminoalkansulfonyl)-derivate von aminoglycosidischen antibiotika und verfahren zur herstellung derselben | |
EP0039967B1 (en) | Solvate of amoxicillin, process for the preparation thereof and process for the preparation of injectable preparations from this solvate | |
DE69910810T2 (de) | Natriumsalz von 3-(4-cinnamyl-1-piperazinyl)-iminomethyl-rifamycin sv und verfahren zu seiner herstellung | |
DE1545838C3 (de) | 7-(2-Azidooctanamido)-cephalosporansäure, deren Salze und Verfahren zur Herstellung dieser Verbindungen | |
DD150352A5 (de) | Verfahren zur herstellung von antibiotikum 7 beta-[d-[carboxy-(4-hydroxyphenyl)acetyl]-7alpha-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.1.0]-oct-2-en-2-carbonsaenrediammoniumsalz | |
DE3745094B4 (de) | Ein kristallines Hydrat der 7ß-[(Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enoylamino]-3-cephem-4-carbonsäure enthaltende Hartgelatinekapsel-Zusammensetzung | |
DE2549733C2 (de) | 1,3-Bis-(β-aethylhexyl)-5-amino-5-methyl-hexahydropyrimidin-terephthalat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel | |
AT393452B (de) | Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung | |
AT337366B (de) | Verfahren zur herstellung von neuen derivaten des cephalosporins und von ihren salzen | |
DE69912959T2 (de) | Eythromycinderivat mit antibiotischer aktivität | |
DE2036073A1 (de) | Neue Penicilline, ihre Herstellung und Verwendung |